180 results on '"M. Tinelli"'
Search Results
2. INFEZIONI EMERGENTI DA CA-MRSA IN ITALIA
- Author
-
M. Monaco, F. D’Ambrosio, M. Venditti, G. Parisi, R. Di Rosa, M. Tinelli, and A. Pantosti
- Subjects
Microbiology ,QR1-502 - Published
- 2007
- Full Text
- View/download PDF
3. P02: PROGNOSTIC STRATIFICATION OF STANDARD RISK MULTIPLE MYELOMA DEFINED BY REVISED ISS
- Author
-
G Barilà, L Bonaldi, A Martines, A Pascarella, S Vedovato, C Clissa, N Macrì, A Bonalumi, L Pavan, M Tinelli, S Nalio, A Teramo, G Calabretto, VR Gasparini, M Krampera, R Bassan, and R Zambello
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2022
- Full Text
- View/download PDF
4. Prevention of the spread of multidrug-resistant organisms in nursing homes
- Author
-
M, Tinelli, G, Tiseo, and M, Falcone
- Subjects
Methicillin-Resistant Staphylococcus aureus ,Aging ,medicine.medical_specialty ,Multidrug-resistant organisms ,03 medical and health sciences ,0302 clinical medicine ,Drug Resistance, Multiple, Bacterial ,Health care ,Antimicrobial stewardship ,Infection control ,Medicine ,Humans ,030212 general & internal medicine ,Aged ,Cross Infection ,Infection Control ,business.industry ,Transmission (medicine) ,Prevention ,Public health ,medicine.disease ,Aged population ,Long-Term Care ,Nursing Homes ,Multiple drug resistance ,Nursing homes ,Medical emergency ,Geriatrics and Gerontology ,business ,030217 neurology & neurosurgery - Abstract
The increase in the aged population led to a global rise in the demand for elderly healthcare services, such as long-term care facilities (LTCFs), nursing homes, residential homes. Unfortunately, the spread of multidrug-resistant organisms (MDROs) in these structures represent an urgent public health threat requiring immediate action. The aim of this review is to provide a practice guide for the prevention of infections in European LTCFs. A team of experts identify specific problems and proposed practical solutions for the management of colonized and infected patients residing in LTCFs. The heterogeneity of LTCF represents one of the main problems for the implementation of standardized surveillance and infection control programs. Crucial steps involved in the spread of infections among LTCF residents are represented by patient's accommodation, MDRO screening on admission, management of patients with rectal colonization by MDROs, management of patients at high risk of MDRO infections, MDRO transmission by staff and implementation of antimicrobial stewardship. Efforts to implement specific actions in each of these fields are required to reduce the infections in this setting.
- Published
- 2019
5. Antimicrobial consumption and impact of antimicrobial stewardship programmes in long-term care facilities
- Author
-
Dafna Yahav, M Tinelli Marco, Marco Falcone, Mical Paul, Barry Cookson, R Güerri-Fernández, Giusy Tiseo, Nico T. Mutters, Virginie Prendki, Gaëtan Gavazzi, and Gabriella Orlando
- Subjects
0301 basic medicine ,Microbiology (medical) ,Male ,medicine.medical_specialty ,030106 microbiology ,Population ,Disease cluster ,law.invention ,03 medical and health sciences ,Antimicrobial Stewardship ,0302 clinical medicine ,Randomized controlled trial ,law ,Intervention (counseling) ,Medicine ,Antimicrobial stewardship ,Humans ,030212 general & internal medicine ,Medical prescription ,Antimicrobial stewardship Elderly Inappropriate antimicrobial therapy Long-term care facilities Multidrug resistance ,Intensive care medicine ,education ,Aged ,Consumption (economics) ,Aged, 80 and over ,education.field_of_study ,Cross Infection ,business.industry ,General Medicine ,Long-Term Care ,Drug Utilization ,Anti-Bacterial Agents ,Long-term care ,Infectious Diseases ,Female ,business - Abstract
Background Antimicrobials are among the most frequently prescribed drugs in long-term care facilities (LTCFs). Implementation of antimicrobial stewardship programmes (ASPs) is often challenging because of scarce data in this setting. Objectives This narrative review aimed to provide data about antibiotic consumption in LTCFs and the need, implementation, and organization of ASPs in this setting. Source PubMed was searched for studies assessing antimicrobial consumption and implementation of ASPs in LTCFs. The search was restricted to articles published in English in the last 10 years. Experts belonging to the ESCMID Study Group for Infections in the Elderly (ESGIE) reviewed the selected studies and evaluated the studies on ASPs according to the GRADE approach. Moreover, the quality of reporting has been assessed according to TREND and CONSORT checklists for quasi-experimental and cluster randomized clinical trials (cRCT), respectively. Content Data on antibiotic consumption in LTCFs show great variability in LTCFs across and within countries. Reasons for this variability are difficult to analyse because of the differences in the types of LTCFs, their organization, and the population cared-for in the different LTCFs. However, studies show that the use of antibiotics among elderly patients in LTCFs, especially in cases of asymptomatic bacteriuria and influenza-like syndromes, is often inappropriate. High-quality cRCTs and low to moderate quality quasi-experimental studies show that educational interventions direct at nurse and physicians are effective in reducing unnecessary antibiotic prescriptions. Implications There is an urgent need for ASPs tailored for LTCFs. Multifaceted organized educational interventions, involving both clinicians and nursing staff, should be advocated and require institutional intervention by health authorities. Future studies assessing the impact of well-defined ASPs in LTCFs should produce compelling evidence in this setting.
- Published
- 2018
6. Correct positioning of pedicle screws with a percutaneous minimal invasive system in spine trauma
- Author
-
M. Adams, Matthias Münzberg, Arnold J. Suda, M. Tinelli, Stefan Matschke, and Paul Alfred Grützner
- Subjects
Spine ORIF ,Adult ,Male ,medicine.medical_specialty ,Percutaneous ,Adolescent ,medicine.medical_treatment ,Bone Screws ,Pedicle screws ,Fracture Fixation, Internal ,Young Adult ,medicine ,Humans ,Minimally Invasive Surgical Procedures ,Orthopedics and Sports Medicine ,Child ,Pedicle screw ,Fracture type ,Aged ,Aged, 80 and over ,business.industry ,Lateral deviation ,Laminectomy ,Mean age ,Minimally invasive spine surgery ,Middle Aged ,Navigation ,Spine trauma ,Surgery ,Case-Control Studies ,Spinal Fractures ,Female ,Radiology ,Tomography, X-Ray Computed ,business ,Minimally invasive spine fixation - Abstract
Background When performing minimally invasive spine surgery in trauma patients, a short operation time and a perfect positioning of pedicle screws are demanded. In this study, we show that a Minimally Invasive Pedicle Screw System allows both. Methods One hundred and twenty-one patients (131 fractures) with fractures between Th 3 and L 5 were treated. The most common fracture type was A3. We treated 52 females and 69 men with a mean age of 56.7 years. In 72% of the cases, the procedure was performed by two experienced spine surgeons. Postoperatively, all patients were examined using a CT-scan. In 61 patients, an anterior stabilization was additionally performed in 33 patients, vertebroplasty or cyphoplasty was performed. Fifteen patients underwent laminectomy. Results No patient postoperatively developed any additional neurological compromise. In total, 682 screws were placed. In the postoperative CT-scan, we found 16 screws (2.2%) in suboptimal position, 8 with medial and 8 with lateral deviation. Discussion With the Minimally Invasive Pedicle Screw System used in this study, spinal fractures can be treated in a short operation time with percutaneous stabilization and a correct positioning of the pedicle screws in almost 98%. In our study, no screw was so much malpositioned that revision surgery would have been necessary. Level of evidence Level III – Case-control study.
- Published
- 2014
- Full Text
- View/download PDF
7. International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings
- Author
-
M. Caremani, R. Perdomo, Z. S. Pawlowski, A. Da Silva, Peter M. Schantz, Dominique A. Vuitton, M. Tinelli, E. Brunettii, L. Lapini, H. Salama, W. Hao, E. Guarnera, H. A. Gharbi, V. Pelaez, A. Teggi, B. Frider, Okan Akhan, Calum N. L. Macpherson, T. Todorov, and C. Felice
- Subjects
medicine.medical_specialty ,Field (physics) ,biology ,Cystic echinococcosis ,business.industry ,Veterinary (miscellaneous) ,Ultrasound ,World Health Organization ,biology.organism_classification ,Hospitals ,Epidemiologic Studies ,Infectious Diseases ,Echinococcosis ,Insect Science ,Epidemiology ,medicine ,Animals ,Humans ,Parasitology ,Radiology ,business ,Echinococcus granulosus ,Ultrasonography - Abstract
The increased knowledge of the natural history of cystic echinococcosis (CE) by the recent expansion in the use of ultrasound (US) in field and clinical studies has necessitated the development of a new WHO standardised classification of US images. Use of such a classification will enable clinicians to examine recommended clinical procedures for the different cyst types. It will also allow scientists to compare data on the occurrence of cyst types in different parts of the world providing evidence to examine strain differences in the causative organism Echinococcus granulosus. The classification proposed follows that of the first classification developed by Gharbi et al. [Radiology 139 (1981) 459] which has been widely used, but in modified forms, since its publication. The classification presented here is intended for use in field epidemiological studies as well as for clinical investigators. The classification is intended to follow the natural history of CE and starts with undifferentiated simple cysts, as presumably hydatid cysts evolve from these structures. These simple cysts, however, may be due to a number of different aetiologies (parasitic lesions, congenital disorders, biliary cysts or neoplasms) and, therefore, require further diagnostic tests to reveal their identity. As their origin is uncertain they are not given the designation of a CE type lesion, and, in the proposed classification, should be recorded as cystic lesions (CL). The first clinical group starts with cyst types CE 1 and 2 and such cysts are active, usually fertile cysts containing viable protoscoleces. CE Type 3 are cysts entering a transitional stage where the integrity of the cyst has been compromised either by the host or by chemotherapy and this transitional stage is assigned to the second clinical group. The third clinical group comprises CE Types 4 and 5 which are inactive cysts which have normally lost their fertility and are degenerative. The use of the standardised US classification will facilitate the application of uniform standards and principles of treatment currently recommended for each cyst type.
- Published
- 2003
- Full Text
- View/download PDF
8. Clinical, serologic and instrumental data of ten patients affected by sclerodermatous chronic graft versus host disease: similarities and differences in respect to systemic sclerosis
- Author
-
I Tinazzi, Domenico Biasi, Cinzia Scambi, M Tinelli, M Sorio, Paola Caramaschi, Giovanni Barausse, L M Bambara, F Benedetti, and Luigi Benini
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pathology ,Anti-nuclear antibody ,systemic sclerosis ,Immunology ,Graft vs Host Disease ,sclerodermatous chronic graft ,host disease ,Skin Diseases ,Scleroderma ,Serology ,immune system diseases ,Immunology and Allergy ,Medicine ,Humans ,Transplantation, Homologous ,Stage (cooking) ,skin and connective tissue diseases ,Pharmacology ,Scleroderma, Systemic ,integumentary system ,business.industry ,Autoantibody ,Hematopoietic Stem Cell Transplantation ,Middle Aged ,medicine.disease ,Dermatology ,Transplantation ,Graft-versus-host disease ,Chronic Disease ,Etiology ,Female ,business - Abstract
Chronic graft versus host disease (cGVHD), the most common late complication of allogeneic haematopoietic stem cell transplantation (HSCT), may present with sclerodermatous lesions resembling in some cases the cutaneous involvement of systemic sclerosis (SSc). Certain pathogenetic findings connect the two diseases. In this report we describe ten subjects affected by cGVHD who underwent the examinations routinely carried out to stage SSc patients. Demographic, clinical, serologic and instrumental data were recorded. These patients showed differences in appearance, extent and progression of the sclerodermatous lesions with greater involvement of the trunk and proximal part of the limbs than the extremities. In seven subjects ANA test was positive; scleroderma-associated autoantibodies were not detected in any of the cases. Moreover, typical organ involvement of SSc was not found. Only one patient developed Raynaud's phenomenon after HSCT and only one patient demonstrated a nailfold videocapillaroscopic scleroderma pattern. Except for cutaneous involvement of cGVHD, that may resemble SSc, the clinical features of the two diseases are quite different, suggesting that the fibrotic process characterizing cGVHD and SSc has different etiologies and different initial pathobiologic events.
- Published
- 2010
9. Enoximone maintains intestinal villus blood flow during endotoxemia
- Author
-
W, Schmidt, M, Tinelli, A, Secchi, M, Gebhard, E, Martin, and H, Schmidt
- Subjects
Male ,Analysis of Variance ,Laparotomy ,Phosphodiesterase Inhibitors ,Microcirculation ,Hemodynamics ,Sensitivity and Specificity ,Endotoxemia ,Rats ,Disease Models, Animal ,Random Allocation ,Reference Values ,Escherichia coli ,Animals ,Intestinal Mucosa ,Rats, Wistar ,Infusions, Intravenous ,Enoximone ,Probability - Abstract
The objective of this study was to determine the effects of a continuous infusion of the phosphodiesterase inhibitor enoximone on mucosal villus blood flow in a normotensive model of endotoxemia.Twenty-four anesthetized and ventilated rats underwent laparotomy and a ileal portion was exteriorized and opened by an antimesenteric incision. The ileal segment was fixed on a plexiglass stage with the mucosal surface upward. Microcirculatory parameters were assessed by intravital videomicroscopy. The animals were randomly assigned to receive one of three treatments: infusion of Escherichia coli lipopolysaccharides (LPS, 2 mg/kg/h) without phosphodiesterase inhibitor pretreatment (LPS group); or infusion of LPS with enoximone pretreatment (10 microg x kg(-1) x min(-1), start 30 min before LPS infusion, enoximone group), or infusion of an eqivalent volume of NaCl 0.9% (control group). Macrohemodynamic parameters (MAP, HR) and microhemodynamic parameters of ileal mucosa (mean diameter of central arterioles = DA, and mean erythrocyte velocity within the arterioles = VE) were measured 30 min before and at 0, 60, and 120 min after induction of endotoxemia. Mucosal villus blood flow was calculated from DA and VE.In this normotensive endotoxemia model MAP remained stable in the control and the LPS group but significantly decreased in the enoximone group. The endotoxin-induced decrease of VE and DE of central arterioles of mucosal villi could be prevented. Thus, mucosal villus blood flow did not decrease compared to the LPS group.Our results indicate that enoximone during an early stage of sepsis contributes to systemic hypotension but prevents mucosal hypoperfusion.
- Published
- 2003
10. PO-0267 Secondary Transport Of Critical Paediatric Patients: Survey In Lombardy
- Author
-
B Cantoni, M Tinelli, and S Maiandi
- Subjects
Service (business) ,Response rate (survey) ,Emergency transport ,business.industry ,Network structure ,medicine.disease ,Patient care ,Nursing ,Critical care nursing ,Pediatrics, Perinatology and Child Health ,Health care ,Medicine ,Medical emergency ,business ,Paediatric patients - Abstract
Background The current health network structure and a lack of a proper filter for pre-hospital care makes every hospital potentially involved into the management of any critical paediatric patient regardless the local experience and organisation. Any first patient’s stabilisation will have to be followed by a secured secondary transport until the hospitalisation at the new facility. Objective Explore the hospitals’ organisational set up concerning the secondary transport of paediatric critical care patients. Materials and methods Structured survey delivered to 92 hospitals in Lombardy Results The response rate was 56%, corresponding to 52 health care facilities. In 29 facilities a dedicated transport service for critical care patients does exist but just in one hospital it’s specific for paediatric patients and it has dedicated staff. Forty facilities are equipped with a paediatric medical bag and the more involved operator is an anesthesiologist for 39% of cases, followed by the paediatrician in 13% of cases. The nurse participates to the transport in 50% of cases; in 28% of the hospitals a critical care nurses is involved, in 7% of cases the nurse is not specialised and in 4% the nurses is specialised in paediatrics. Discussion The data shows an non homogeneity management of the critical care patient secondary transport. Conclusions It’s highly desirable the activation of a secondary transport service with an organisational level compared to the neonatal emergency transport service because the child has its own characteristics as like as the newborn or the adult.
- Published
- 2014
- Full Text
- View/download PDF
11. Placement exact des vis pédiculaires par un système d’ostéosynthèse percutané mini-invasif dans les traumatismes rachidiens
- Author
-
M. Tinelli, Matthias Münzberg, M. Adams, Arnold J. Suda, Paul Alfred Grützner, and Stefan Matschke
- Subjects
medicine.medical_specialty ,Percutaneous ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,Lateral deviation ,Laminectomy ,Computed tomography ,Mean age ,Minimally invasive spine surgery ,Surgery ,medicine ,Orthopedics and Sports Medicine ,Pedicle screw ,business ,Fracture type - Abstract
Background When performing minimally invasive spine surgery in trauma patients, a short operation time and a perfect positioning of pedicle screws are demanded. In this study, we show that a minimally invasive pedicle screw system allows both. Methods One hundred and twenty-one patients (131 fractures) with fractures between Th 3 and L 5 were treated. The most common fracture type was A3. We treated 52 females and 69 men with a mean age of 56.7 years. In 72% of the cases, the procedure was performed by two experienced spine surgeons. Postoperatively, all patients were examined using a CT scan. In 61 patients, an anterior stabilization was additionally performed in 33 patients, vertebroplasty or cyphoplasty was performed. Fifteen patients underwent laminectomy. Results No patient, postoperatively, developed any additional neurological compromise. In total, 682 screws were placed. In the postoperative CT scan, we found 16 screws (2.2%) in suboptimal position, 8 with medial and 8 with lateral deviation. Discussion With the minimally invasive pedicle screw system used in this study, spinal fractures can be treated in a short operation time with percutaneous stabilization and a correct positioning of the pedicle screws in almost 98%. In our study, no screw was so much malpositioned that revision surgery would have been necessary. Level of evidence Level III Case-control study.
- Published
- 2014
- Full Text
- View/download PDF
12. Dot immunobinding assay as a new diagnostic test for human hydatid disease
- Author
-
M. Tinelli, P. Falagiani, D. Roncarolo, G. Riva, G. Mistrello, and M. Gentili
- Subjects
Pathology ,medicine.medical_specialty ,Echinococcosis, Hepatic ,Immunology ,Immunoblotting ,Antibodies, Helminth ,Enzyme-Linked Immunosorbent Assay ,Disease ,Epitope ,In vitro diagnostic ,Epitopes ,Radioallergosorbent Test ,Antigen ,Antibody Specificity ,parasitic diseases ,medicine ,Immunology and Allergy ,Animals ,Humans ,biology ,medicine.diagnostic_test ,business.industry ,Radioallergosorbent test ,Diagnostic test ,biology.organism_classification ,Echinococcus ,Antigens, Helminth ,biology.protein ,Cattle ,Electrophoresis, Polyacrylamide Gel ,Antibody ,business - Abstract
Bovine and human hydatid antigens collected from hepatic cysts and characterized by SDS-PAGE immunoblotting show similar patterns. The bovine hydatid antigen has been used to develop a simple and fast in vitro diagnostic assay for human hydatidosis. This method, named HA-DIA (hydatid antigen dot immunobinding assay), consists of incubation of a serum sample with a textile colloidal dye (pink) and a nitrocellulose stick to which the hydatid antigen has been bound. The presence of parasite-specific antibodies leads to dyeing of the stick reactive area, and a coloured spot appears. HA-DIA sensitivity and specificity have been studied in comparison with RAST-IgE and ELISA-IgG by testing 17 sera of patients with hydatid disease and 36 control sera from patients affected with other parasitic and non-parasitic diseases. HA-DIA showed positive results in all the patients' sera and in none of the control sera. Correlation with ELISA--IgG and RAST-IgE was significant. HA-DIA has been demonstrated to be of good predictive value, allowing a speedy diagnosis of hydatid disease. In view of its simplicity, not requiring any laboratory instruments, it is particularly suitable for large-scale field screening.
- Published
- 1995
13. Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users
- Author
-
G, Filice, S, Patruno, D, Campisi, A, Chiesa, P, Orsolini, M, Debiaggi, R, Bruno, and M, Tinelli
- Subjects
Immunoenzyme Techniques ,Humans ,False Positive Reactions ,HIV Infections ,Hepacivirus ,Hepatitis Antibodies ,HIV Antibodies ,Hepatitis C Antibodies ,Substance Abuse, Intravenous ,Hepatitis C ,Sensitivity and Specificity - Abstract
Serum samples from 487 ambulatory I.V. drug users were screened for HIV and HCV antibodies to determine the prevalence of coinfection in this high risk group for AIDS. For anti-HCV antibody screening we first used a 3rd generation EIA using, as antigen synthetic peptides which were not subjected to false positive results due to antibodies against superoxide dismutase or against yeast proteins (which may copurify with the recombinant proteins employed in the first and second generation test). The specimens that were positive in the screening test were confirmed by a more specific EIA system that detect antibodies to proteins encoded by structural (HCV-st EIA) and non structural (HCV-nst-EIA) regions of the HCV genome. A second confirmation assay was also performed: sera were run in presence or absence of blocking reagents which inhibits antibodies to C200 and C22 HCV epitopes for binding to the solid phase. The sensitivity of the HCV EIA screening for human HCV antibody detection revealed a 100% positivity for HCV infection. The confirmatory strategy presented in this paper revealed an HCV EIA specificity of 98.6%. In this work we demonstrated a significantly higher prevalence (p0.001) of HCV exposure in HIV infected individuals compared to the general population. Our experimental data also confirmed that HBV infection in drug-users at high risk for HIV infection was significantly associated with HCV infection (p0.001). In contrast, the acquisition of HIV by sexual contact was not a statistically significant risk factor for HCV coinfection.
- Published
- 1993
14. Recurrent Histoplasma capsulatum pneumonia: a case report
- Author
-
M, Tinelli, G, Michelone, and C, Cavanna
- Subjects
Adult ,Male ,Occupational Diseases ,Ketoconazole ,Recurrence ,Amphotericin B ,Humans ,Dust ,Pneumonia ,Histoplasmosis - Abstract
The epidemiological, clinical and therapeutical findings are described in a case of recurrent pulmonary histoplasmosis due to Histoplasma capsulatum. The patient, a bulldozer-operator, worked in Africa for a long period in extremely dusty conditions without any protection. Three different episodes of H. capsulatum pneumonia recurred during eighteen months after his return from Africa. A full dose treatment by Amphotericin B failed to eliminate disease recurrence on three occasions. The high concentration of airborne H. capsulatum spores inhaled could have been the main cause of the difficulty obtaining a rapid sterilization of the microorganism by Amphotericin B and disease recurrence. The late start of the treatment or the unexplained ability of some persons to develop repeated infections even with normal immunological parameters could be another explanation for the reported phenomenon.
- Published
- 1992
15. [Follow-up and long-term treatment of infections caused by human cytomegalovirus in 3 patients with AIDS]
- Author
-
M, Tinelli, M, Parea, A, Maccabruni, and F, Tacconi
- Subjects
Adult ,Acquired Immunodeficiency Syndrome ,Time Factors ,Cytomegalovirus Infections ,Retinitis ,Eye Infections, Viral ,Humans ,Female ,Ganciclovir ,Follow-Up Studies - Abstract
We report the follow-up and treatment of HCMV infections in three patients with AIDS. The patients, affected by HCMV retinitis, have been followed 24, 12 and 6 months respectively. The antiviral treatment was based on the DHPG administration which was substituted in one case of resistance to DHPG with Foscarnet. In the follow-up period, virological tests have been performed to detect the presence of the HCMV antigenemia/viremia. The results show that, to avoid the progression of the retinitis, the antiviral treatment must not be stopped or discontinued. DHPG and Foscarnet were able to limit the infection to the eye and were well tolerated. In the HCMV-infected patients, the continuous monitoring of the antigenemia/viremia is of main importance to follow the clinical and therapeutical course of the disease.
- Published
- 1991
16. Cytomegalovirus prophylaxis by intravenous immunoglobulins in five heart transplanted patients
- Author
-
M, Tinelli, E, Percivalle, A, Zambelli, P, Grossi, and A, Maccabruni
- Subjects
Male ,Immunocompromised Host ,Postoperative Complications ,Evaluation Studies as Topic ,Neutralization Tests ,Cytomegalovirus Infections ,Cytomegalovirus ,Heart Transplantation ,Humans ,Immunoglobulins, Intravenous ,Female ,Antibodies, Viral ,Antigens, Viral - Abstract
The present study was set up to evaluate the efficacy of hyperimmune anti-CMV immunoglobulins (IVIG) in the prophylaxis of CMV infection in five patients suffering from dilatative myocardiopathy and submitted to hearth transplant. Different commercial IVIG were tested for anti-CMV neutralizing antibodies before administrated them to patients; the lots immunochemically prepared by PEG resulted to have the highest anti-CMV titer. IVIG treatment, when administered at high doses and at closes intervals of time, proved able to prevent and control CMV infections; when treatment was stopped, a primary infection occurred, easily controlled by short courses of DHPG. Even if our survey was limited to only five cases, it should be emphasized that after the suspension of the therapy, clinical symptoms were restricted to simple mononucleosis syndrome without organ disease. Furthermore it should be noted that during IVIG therapy no immediate or delayed adverse effects were observed.
- Published
- 1990
17. [Diagnostic definition of cerebral lesions in a case of AIDS: importance of the use of magnetic resonance]
- Author
-
M, Tinelli, P, Pricca, and A, Maccabruni
- Subjects
Adult ,Acquired Immunodeficiency Syndrome ,Brain Diseases ,Humans ,Female ,Magnetic Resonance Imaging - Abstract
The present study describes a case of AIDS with asymptomatic intracranial focal lesions. The DDD-enhancement CT technique detected the lesions as inflammatory or neoplastic. A subsequent MR demonstrated the vascular nature of the intracranial findings. MR in the neuropathology of AIDS can be of primary importance in the detection of the intracranial focal lesions, thus avoiding a cerebral stereotaxic needle biopsy.
- Published
- 1990
18. Report of the symposium on the use of intravenous gammaglobulin in adults infected with the human immunodeficiency virus
- Author
-
Salvatore Antonaci, F. Milazzo, John W. Hadden, G. Scalise, M. Chirigos, R. Lockey, S. Di Fabio, M. Tinelli, Emilio Jirillo, C. De Simone, Salvatore Delia, and R. A. Good
- Subjects
Microbiology (medical) ,Adult ,medicine.medical_specialty ,Clinical Biochemistry ,Human immunodeficiency virus (HIV) ,HIV Infections ,medicine.disease_cause ,law.invention ,Zidovudine ,Randomized controlled trial ,Acquired immunodeficiency syndrome (AIDS) ,Clinical Protocols ,law ,medicine ,Immunology and Allergy ,Humans ,Intensive care medicine ,Clinical Trials as Topic ,business.industry ,Biochemistry (medical) ,Public Health, Environmental and Occupational Health ,Immunization, Passive ,Intravenous gammaglobulin ,Hematology ,medicine.disease ,Immunopharmacology ,Persistent generalized lymphadenopathy ,Medical Laboratory Technology ,Immunology ,Injections, Intravenous ,Immunotherapy ,gamma-Globulins ,Immunocompetence ,business ,medicine.drug - Abstract
On July 27, 1989, the International Conference on Molecular Aspects of Immune Response and Infectious Diseases devoted a symposium to the subject of the use of intravenous gamma globulin (IVIG) in acquired immunodeficiency syndrome (AIDS). The information presented confirmed that IVIG benefits human immunodeficiency virus (HIV)-infected children with recurrent infections and that much remains to be learned about the influence of IVIG in adult AIDS. The symposium participants recognized the urgent need to develop randomized clinical trials using a control group to assess the efficacy of a treatment with IVIG in PGL (persistent generalized lymphadenopathy), ARC (AIDS-related complex), and AIDS. To prepare this report, a committee was established, including individuals with expertise in immunology, immunopharmacology, microbiology, virology, infectious diseases, general medicine, and pediatrics and representing research experience in academia and hospitals. After an introduction to the report with a summary of immunotherapeutic agents under evaluation to treat HIV infection, section 1 lays out the present understanding of the disease pathogenesis. Section 2 then outlines the treatment of HIV-seropositive individuals, discussing the uncertainties that any treatment entails. Section 3 discusses the rationale for treating HIV-infected individuals with WIG, and Section 4 examines the major differences between IVIG and hyperimmuneglobulins for the treatment of HIV infection. Section 5 looks at IVIG as a mean to delay the emergence of opportunistic infections and restore immunocompetence in AIDS and related illnesses, and Sections 6 and 7 suggest a pilot protocol on the use of WIG in association with low-dose or standard-dose zidovudine (AZT). Limited time precluded the committee's addressing certain important aspects, and it must be remembered that, since this report represents the committee evaluations as of July 1989, the use of WIG in adults infected with HIV should be studied on a continuous basis according to more up-todate knowledge of HIV infection.
- Published
- 1990
19. Mass Lesions of the Larynx Due to Cytomegalovirus Infection in a Patient Infected with the Human Immunodeficiency Virus
- Author
-
S. Caprioglio, A. Panigazzi, Paolo Castelnuovo, M. Tinelli, and F. D'Andrea
- Subjects
Microbiology (medical) ,Cytomegalovirus infection ,Larynx ,Infectious Diseases ,medicine.anatomical_structure ,business.industry ,Human immunodeficiency virus (HIV) ,medicine ,medicine.disease_cause ,business ,Virology - Published
- 1995
- Full Text
- View/download PDF
20. Parasite-Reactive Serum IgE Antibodies in African Populations. Relation to Intestinal Parasite Load
- Author
-
M. Tinelli, S. D. Jayakar, M. Scaglia, A. Peracino, A. G. Siccardi, J.C. Desmarais, and R. Revoltella
- Subjects
Nematoda ,Immunology ,Radioimmunoassay ,Intestinal parasite ,Cross Reactions ,Immunoglobulin E ,medicine.disease_cause ,Histamine Release ,Epitope ,Microbiology ,Entamoeba ,Epitopes ,parasitic diseases ,medicine ,Humans ,Immunology and Allergy ,Parasite hosting ,Helminths ,biology ,Ascaris ,Entamoeba histolytica ,Rwanda ,General Medicine ,biology.organism_classification ,biology.protein ,Antibody - Abstract
Serum IgE levels and IgE antibodies against four intestinal parasites, and the presence and abundance of parasites in stool samples were investigated in 161 Rwanda natives. Most of the IgE turn out to be helminth-reacting antibodies. The stimulation and production of these antibodies are much different from those of anti-amoeba antibodies in their relation to the specific intestinal parasite load; helminth infestations seem to play a major role in the development of anti-amoeba antibodies as well.
- Published
- 1980
- Full Text
- View/download PDF
21. Contents, Vol. 59, 1979
- Author
-
T.R. Deline, Yasuhiko Kano, S.O. Emejuaiwe, M. Tinelli, P. Eyre, Satoru Oka, Tetsuo Shimada, Christopher J. Meade, Takeru Ishikawa, Bernard J. De Cueninck, Rokuro Okuda, Hidenori Suzuki, D. Mancino, Elizabeth J. Harling, Takami Yoshida, Tadashi Kawai, Yoshihisa Itoh, B.F. Jones, H.O. Hanson, E. Penner, S.Y. Li Hsü, Keisuke Shinomiya, P. Falagiani, S.D. Jayakar, Haruki Mikawa, H.F. Hsü, Takao Hirao, Toshihiko Jyo, M.R. Robertson, J.W. Quin, Kunio Haga, Yoshinobu Yamamoto, N. Bevilacqua, Kohei Shioiri-Nakano, Herbert Megel, R.H. Holloway, Moriyasu Tsuji, Tiuzi Sindo, Nobuko Kessoku, H.J. Schiller, A. Peracino, Masayoshi Kiyoi, H.F. Cheng, R. Revoltella, Kyosuke Ozawa, G.D. Penick, T.J. Sharpe, A.G. Siccardi, J.A. Charlesworth, Tadashi Kasahara, J.C. Desmarais, M. Scaglia, F. Milgrom, Kohjin Kin, Donald L. Denney, Yuzuru Hayashi, and H. Smith
- Subjects
business.industry ,Immunology ,Immunology and Allergy ,Medicine ,General Medicine ,business - Published
- 1979
- Full Text
- View/download PDF
22. Relationship between Serum IgE Levels and Intestinal Parasite Load in African Populations
- Author
-
J.C. Desmarais, M. Scaglia, A. G. Siccardi, S. D. Jayakar, P. Falagiani, M. Tinelli, A. Peracino, and R. Revoltella
- Subjects
Ascariasis ,Entamoebiasis ,Ascaris ,Immunology ,Rwanda ,Ethnic group ,Intestinal parasite ,Amebiasis ,General Medicine ,Immunoglobulin E ,Biology ,medicine.disease_cause ,Serum ige ,Entamoeba ,Trichuris ,medicine ,Humans ,Immunology and Allergy ,Trichuriasis - Abstract
Serum IgE determinations and coproparasitological analyses were carried out on 161 individuals from two distinct ethnic groups (Hutus and Twas) from two regions in Rwanda (North and South). The cumulative parasitosis index (calculated for each individual as the sum of the scores for the four most frequent intestinal parasites) shows a linear relation with IgE levels up to a plateau, with no clear pattern of correlation between the score for any given parasite and the IgE level. Such a direct quantitative (but not qualitative) relation reproposes the question on the role of IgE immunoglobulins in intestinal parasitoses.
- Published
- 1979
- Full Text
- View/download PDF
23. [Septic thrombosis of the cavernous sinus. Presentation of a clinical case]
- Author
-
F, Milano, P, Viale, M, Tinelli, L, Ghezzi, and A, Maccabruni
- Subjects
Diagnosis, Differential ,Male ,Sinus Thrombosis, Intracranial ,Adolescent ,Oculomotor Nerve ,Humans ,Cavernous Sinus ,Skin Diseases, Infectious ,Staphylococcal Infections ,Cranial Nerve Diseases ,Facial Dermatoses - Abstract
This paper describes a case of cavernous sinus septic thrombosis with cerebellar complication. The CNS was involved after a primitive piodermitis of the face. The diagnostic tools employed in the management of the case and the therapeutic procedures in the acute phase and in the convalescence are discussed. The patient completely recovered after chemotherapeutic treatment.
- Published
- 1989
24. [Chemoluminescence in the prevention of leukocyte injury caused by antibiotics]
- Author
-
D, Scevola, E, Concia, M, Tinelli, V, Monzillo, and C, Oppezzo
- Subjects
Phagocytosis ,Neutrophils ,Luminescent Measurements ,Humans ,Anti-Bacterial Agents - Published
- 1985
25. RAST and ELISA in three autochthonous parasitic infections in Italy: toxocariasis, hydatidosis and fascioliasis
- Author
-
M, Tinelli, P, Falagiani, G, Riva, and C, Genchi
- Subjects
Ascariasis ,Fascioliasis ,Toxocariasis ,Radioimmunoassay ,Enzyme-Linked Immunosorbent Assay ,Fasciola hepatica ,Immunoglobulin E ,Echinococcus ,Radioallergosorbent Test ,Echinococcosis ,Antigens, Helminth ,Immunoglobulin G ,Animals ,Humans ,Toxocara - Abstract
Toxocariasis, Hydatidosis and Fascioliasis are common autochthonous parasitic infections in Italy. RAST and ELISA have been evaluated for serological diagnosis. Eight sera from Toxocariasis, fifty from Hydatidosis and two from Fascioliasis have been examined. Excretory/secretory antigen has been employed for the serology of Toxocariasis, hydatic fluid for Hydatidosis and embryonated-eggs antigen for Fascioliasis. The RAST resulted positive in 4/5 cases of the visceral form of Toxocariasis and 3/3 in the ocular form, in 2/2 cases of Fascioliasis and 27/50 of Hydatidosis. The ELISA resulted positive respectively in 5/5, 3/3, 2/2, and 19/50 cases. The sensitivity and specificity of the tests employed have been proved.
- Published
- 1987
26. [Clinical review of 3 cases of aspergillosis]
- Author
-
G, Michelone, A, Maccabruni, A, Matteelli, P L, Garavelli, and M, Tinelli
- Subjects
Adult ,Male ,Adolescent ,Plasma Exchange ,Amphotericin B ,Liver Diseases ,Aspergillosis, Allergic Bronchopulmonary ,Aspergillosis ,Humans ,Female ,Spinal Diseases ,Middle Aged ,Intervertebral Disc - Abstract
Three cases of aspergillosis observed in Pavia Infectious Disease Clinic in 1983-85 are described. The cases differed both in the site of the infection (lungs, bones and liver) and in the patients' basic immunological situation. The importance of mycological investigations during diagnosis is emphasised, though they should of course be flanked by instrumental examinations and blood chemical assays. The efficacy of specific treatment with amphotericin B combined with surgery and plasma exchange is also emphasised.
- Published
- 1988
27. Chemiluminescence, phagocytosis, chemotaxis and killing activity of human leukocytes exposed to Clindamycin
- Author
-
D, Scevola, E, Concia, M, Tinelli, R, Benzi, V, Monzillo, and G, Cremonesi
- Subjects
Chemotaxis, Leukocyte ,Phagocytosis ,Neutrophils ,Clindamycin ,Luminescent Measurements ,Humans - Abstract
We measured the chemiluminescence (CL) of human leukocytes (PMNs) exposed to different concentrations of Clindamycin (1; 5; 1 mcg/ml) using a standardized luminolamplified reagent-instrument methodology (Auto Picolite 6500 Luminometer and ZAP/Picolite Kits, Packard Instruments Co. Drowners Grove, IL. USA). Cells obtained from healthy donors were also tested for chemotaxis with Boyden chambers, for phagocytosis and for killing activity against Staphylococcus aureus by the agar-medium culture plate technique. Clindamycin does not induce significant variations of the CL response in whole blood, or changes in phagocytosis and killing activity. On the contrary, concentrations of drug corresponding to therapeutically obtainable levels significantly increase light emission by isolated cells. A concentration effect was seen on leukotaxis, that was increased, but not significantly, at 1 and 5 mcg/ml and decreased (P less than 0.01) at 10 mcg/ml. CL assay is a simple, sensitive, reproducible technique to assess the PMNs functions during antibiotic therapy.
- Published
- 1986
28. [Comparative statistical study of erythropoiesis in HBsAg- and HBsAg+ hepatitis]
- Author
-
M, Tinelli, P, Periti, G, Barbarini, and P, Marone
- Subjects
Adult ,Male ,Hepatitis B Surface Antigens ,Adolescent ,Hepatitis, Viral, Human ,Middle Aged ,Hepatitis B ,Erythrocyte Count ,Hemoglobinometry ,Humans ,Erythropoiesis ,Female ,Diagnosis, Computer-Assisted ,Child ,Aged ,Erythrocyte Volume - Published
- 1977
29. Pulmonary aspergillosis in a case of humoral immunodeficiency
- Author
-
M, Tinelli, A, Zambelli, C, Cavanna, and G, Michelone
- Subjects
Radiography ,Adolescent ,Aspergillosis, Allergic Bronchopulmonary ,Immunologic Deficiency Syndromes ,Humans ,Female - Abstract
A case of recurrent pulmonary aspergillosis in a young girl with common variable hypogammaglobulinaemia and the treatment adopted is described. We employed the plasma-exchange, at the beginning of immunosubstitutive treatment, to provide a high serum concentration of all classes of immunoglobulins and to better control the patient's state of shock. Intravenous immunoglobulins and Amphotericin B were also given in combination with plasma-exchange, having a synergic therapeutic effect. The good condition of the patient, despite the recurrent episodes of fungal pneumonia, suggests that such an approach can lead to long-term, high quality survival in humoral immunodeficient patients.
- Published
- 1987
30. [Observations about the use of different types of enzymes in immunohistological diagnosis of autoimmune diseases. Comparative study with indirect immunofluorescence technique (author's transl)]
- Author
-
M, Tinelli, F, Legnani, G, Santi, G, Barbarini, and A, Giulivi
- Subjects
Immunoenzyme Techniques ,Glucose Oxidase ,Peroxidases ,Evaluation Studies as Topic ,Animals ,Fluorescent Antibody Technique ,Humans ,Alkaline Phosphatase ,Autoantibodies ,Autoimmune Diseases ,Rats - Abstract
The Authors have evaluated the use of anti-human immunoglobulins conjugated with peroxidase, alkaline-phosphatase, glucose-oxidase as a diagnostic tool for assaying autoantibodies. A comparison study was done using the classical indirect immunofluorescence technique. Immunoenzymatic techniques, of minor cost compared to immunofluorescence, have revealed a better appreciation of global and particular structure of the tissue in examination. From the three enzymes examined peroxidase revealed itself as first choice, because, other than having on overlapping sensitivity to immunofluorescence, it can allow a further ultrastructural study.
- Published
- 1979
31. Morphological, cytochemical and ultrastructural studies of a case of systemic mastocytosis
- Author
-
A, Malfitano, L, Minoli, R, Invernizzi, P, Lanzarini, M, Tinelli, and E G, Rondanelli
- Subjects
Male ,Staining and Labeling ,Middle Aged ,Periodic Acid-Schiff Reaction ,Alkaline Phosphatase ,Microscopy, Electron ,Liver ,Bone Marrow ,Urticaria Pigmentosa ,Humans ,Lymph Nodes ,Mast Cells ,Tolonium Chloride ,Carboxylic Ester Hydrolases - Abstract
Morphological, cytochemical and ultrastructural studies of mast cells were carried out in a patient affected with systemic mastocytosis. Neoplastic mast cells showed morphological features between classic tissue mast cells and circulating basophils. They showed strong granule metachromasia after toluidine blue, faint positivity to Hotchkiss reaction, strong positivity to chloroacetate esterase, while they were negative to alkaline phosphatase. Ultrastructural observations showed heterogeneity of granules, most of which had homogenous fine dotted contents. The origin and linkage between mast cells and circulating basophils are discussed.
- Published
- 1983
32. Cellular inflammatory responses to killed salmonella typhosa in typhoid fever patients
- Author
-
E, Magliulo, D, Scevola, D, Fumarola, M, Azzini, and M, Tinelli
- Subjects
Adult ,Inflammation ,Male ,Skin Window Technique ,Chemotaxis ,Humans ,Female ,Middle Aged ,Salmonella typhi ,Typhoid Fever ,Monocytes ,Granulocytes - Published
- 1975
33. Serodiagnosis of ocular toxocariasis: a comparison of specific IgE and IgG
- Author
-
M. Tinelli, P. Falagiani, C. Genchi, and F. Brunello
- Subjects
Ocular toxocariasis ,Eye Diseases ,biology ,business.industry ,Public Health, Environmental and Occupational Health ,Enzyme-Linked Immunosorbent Assay ,General Medicine ,Immunoglobulin E ,Infectious Diseases ,Immunoglobulin G ,Immunology ,Larva Migrans, Visceral ,biology.protein ,Humans ,Medicine ,Parasitology ,business - Published
- 1986
- Full Text
- View/download PDF
34. Editorial. Valuing headache’s solution
- Author
-
TJ Steiner and M Tinelli
- Subjects
Headache ,Structured headache services ,Economic analysis ,Value of treatment ,Health policy ,Global Campaign against Headache ,Medicine - Published
- 2021
- Full Text
- View/download PDF
35. L’economia produttiva animale: risultati delle analisi archeozoologiche nel Villaggio Medievale di Apigliano (Martano, LE)
- Author
-
DE GROSSI MAZZORIN, Jacopo, DE VENUTO, GIOVANNI, P. Arthur. M. Leo Imperiale, M. Tinelli (a cura di), DE GROSSI MAZZORIN, Jacopo, and DE VENUTO, Giovanni
- Subjects
apigliano, bizantini, archeozoologia, economia animale - Published
- 2015
36. Nef-specific CD45RA+ CD8+ T cells secreting MIP-1β but not IFN-γ are associated with nonprogressive HIV-1 infection
- Author
-
Volker Erfle, Thomas Vollbrecht, Ulrike Protzer, Elisa Vicenzi, Simone Allgayer, Silvia Heltai, Paolo Lusso, Guido Poli, Elena Santagostino, Giuseppe Tambussi, Mauro S. Malnati, Marco Tinelli, Sarah Kutscher, Dieter Hoffmann, Hans Jürgen Stellbrink, Claudia J. Dembek, Frank D. Goebel, Peter Reitmeir, Rika Draenert, Johannes R. Bogner, Priscilla Biswas, Silvia Ghezzi, Antonio Cosma, C. J., Dembek, S., Kutscher, S., Allgayer, S., Heltai, P., Biswa, S., Ghezzi, E., Vicenzi, D., Hoffman, P., Reitmeir, G., Tambussi, J. R., Bogner, P., Lusso, H. J., Stellbrink, E., Santagostino, T., Vollbrecht, F. D., Goebel, U., Protzer, R., Draenert, M., Tinelli, Poli, Guido, V., Erfle, M., Malnati, and A., Cosma
- Subjects
lcsh:Immunologic diseases. Allergy ,education.field_of_study ,T cell ,Research ,Population ,virus diseases ,Biology ,medicine.disease ,Phenotype ,Virology ,medicine.anatomical_structure ,Immune system ,Viral replication ,Immunology ,medicine ,Cytotoxic T cell ,Molecular Medicine ,Pharmacology (medical) ,education ,lcsh:RC581-607 ,Progressive disease ,CD8 - Abstract
Background Long-term survival of HIV-1 infected individuals is usually achieved by continuous administration of combination antiretroviral therapy (ART). An exception to this scenario is represented by HIV-1 infected nonprogressors (NP) which maintain relatively high circulating CD4+ T cells without clinical symptoms for several years in the absence of ART. Several lines of evidence indicate an important role of the T-cell response in the modulation of HIV-1 infection during the acute and chronic phase of the disease. Results We analyzed the functional and the differentiation phenotype of Nef- and Tat-specific CD8+ T cells in a cohort of HIV-1 infected NP in comparison to progressors, ART-treated seropositive individuals and individuals undergoing a single cycle of ART interruption. We observed that a distinctive feature of NP is the presence of Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma. This population was present in 7 out of 11 NP. CD45RA+ IFN-gammaneg MIP-1beta+ CD8+ T cells were not detected in HIV-1 infected individuals under ART or withdrawing from ART and experiencing a rebounding viral replication. In addition, we detected Nef-specific CD45RA+ IFN-gammaneg MIP-1beta+ CD8+ T cells in only 1 out of 10 HIV-1 infected individuals with untreated progressive disease. Conclusion The novel antigen-specific CD45RA+ IFN-gammaneg MIP-1beta+ CD8+ T cell population represents a new candidate marker of long-term natural control of HIV-1 disease progression and a relevant functional T-cell subset in the evaluation of the immune responses induced by candidate HIV-1 vaccines.
- Published
- 2010
37. Using choice modelling to inform service sustainability for dementia Meeting Centres for people living with dementia in the UK.
- Author
-
Tinelli M, Morton T, Bray J, Henderson C, Frost F, and Evans S
- Subjects
- Humans, Male, Female, United Kingdom, Aged, Middle Aged, Aged, 80 and over, Adult, Surveys and Questionnaires, Social Support, Dementia therapy, Caregivers psychology, Choice Behavior
- Abstract
Objectives: This study explores the preferences and willingness-to-pay (WTP) of carers for Meeting Centres (MCs) attributes in assisting individuals with mild to moderate dementia., Method: Preferences from 108 carers, gathered through UK-wide MC networks, were collected using a Discrete Choice Experiment survey. The survey incorporated attributes derived from evidence synthesis and lay consultation. A regression model estimated preference weights and marginal WTP for a change in attributes one a time within the MC support 'package.', Results: Carers preferred MCs offering a balanced mix of practical activities and emotional support, along with flexibility without booking requirements and low costs. Social opportunities and the frequency of the meeting were not prioritised. Respondents expressed a WTP of £43 to stay with 'My MC,' the preferred option, compared to transitioning to an alternative in-person MC, all else being equal. Various factors, including attendance modality, the relationship with the supported person, age, and gender, influenced carers' choices., Conclusion: These findings offer valuable insights into carers' preferences, priorities, and WTP within MC support for those with mild to moderate dementia. Understanding these factors can guide the implementation and sustainability of MCs, ensuring alignment with carers' needs and preferences and, ultimately, enhancing support for individuals with dementia.
- Published
- 2024
- Full Text
- View/download PDF
38. Hallmarks of primary headache: part 1 - migraine.
- Author
-
Raggi A, Leonardi M, Arruda M, Caponnetto V, Castaldo M, Coppola G, Della Pietra A, Fan X, Garcia-Azorin D, Gazerani P, Grangeon L, Grazzi L, Hsiao FJ, Ihara K, Labastida-Ramirez A, Lange KS, Lisicki M, Marcassoli A, Montisano DA, Onan D, Onofri A, Pellesi L, Peres M, Petrušić I, Raffaelli B, Rubio-Beltran E, Straube A, Straube S, Takizawa T, Tana C, Tinelli M, Valeriani M, Vigneri S, Vuralli D, Waliszewska-Prosół M, Wang W, Wang Y, Wells-Gatnik W, Wijeratne T, and Martelletti P
- Subjects
- Humans, Migraine Disorders therapy, Migraine Disorders diagnosis, Migraine Disorders physiopathology
- Abstract
Background and Aim: Migraine is a common disabling conditions which, globally, affects 15.2% of the population. It is the second cause of health loss in terms of years lived with disability, the first among women. Despite being so common, it is poorly recognised and too often undertreated. Specialty centres and neurologists with specific expertise on headache disorders have the knowledge to provide specific care: however, those who do not regularly treat patients with migraine will benefit from a synopsis on the most relevant and updated information about this condition. This paper presents a comprehensive view on the hallmarks of migraine, from genetics and diagnostic markers, up to treatments and societal impact, and reports the elements that identify migraine specific features., Main Results: The most relevant hallmark of migraine is that it has common and individual features together. Besides the known clinical manifestations, migraine presentation is heterogeneous with regard to frequency of attacks, presence of aura, response to therapy, associated comorbidities or other symptoms, which likely reflect migraine heterogeneous genetic and molecular basis. The amount of therapies for acute and for prophylactic treatment is really wide, and one of the difficulties is with finding the best treatment for the single patient. In addition to this, patients carry out different daily life activities, and might show lifestyle habits which are not entirely adequate to manage migraine day by day. Education will be more and more important as a strategy of brain health promotion, because this will enable reducing the amount of subjects needing specialty care, thus leaving it to those who require it in reason of refractory condition or presence of comorbidities., Conclusions: Recognizing the hallmarks of migraine and the features of single patients enables prescribing specific pharmacological and non-pharmacological treatments. Medical research on headaches today particularly suffers from the syndrome of single-disease approach, but it is important to have a cross-sectional and joint vision with other close specialties, in order to treat our patients with a comprehensive approach that a heterogeneous condition like migraine requires., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
39. Treatment methods for cervical intraepithelial neoplasia in England: A cost-effectiveness analysis.
- Author
-
Tinelli M, Athanasiou A, Veroniki AA, Efthimiou O, Kalliala I, Bowden S, Paraskevaidi M, Lyons D, Martin-Hirsch P, Bennett P, Paraskevaidis E, Salanti G, Kyrgiou M, and Naci H
- Subjects
- Adult, Female, Humans, Middle Aged, Pregnancy, Young Adult, Colposcopy economics, Conization economics, England, Neoplasm Recurrence, Local economics, Premature Birth economics, Premature Birth epidemiology, Treatment Outcome, Cost-Effectiveness Analysis, Uterine Cervical Dysplasia economics, Uterine Cervical Dysplasia surgery, Uterine Cervical Dysplasia therapy, Uterine Cervical Neoplasms economics, Uterine Cervical Neoplasms therapy, Uterine Cervical Neoplasms surgery
- Abstract
Objective: To compare the cost-effectiveness of different treatments for cervical intraepithelial neoplasia (CIN)., Design: A cost-effectiveness analysis based on data available in the literature and expert opinion., Setting: England., Population: Women treated for CIN., Methods: We developed a decision-analytic model to simulate the clinical course of 1000 women who received local treatment for CIN and were followed up for 10 years after treatment. In the model we considered surgical complications as well as oncological and reproductive outcomes over the 10-year period. The costs calculated were those incurred by the National Health Service (NHS) of England., Main Outcome Measures: Cost per one CIN2+ recurrence averted (oncological outcome); cost per one preterm birth averted (reproductive outcome); overall cost per one adverse oncological or reproductive outcome averted., Results: For young women of reproductive age, large loop excision of the transformation zone (LLETZ) was the most cost-effective treatment overall at all willingness-to-pay thresholds. For postmenopausal women, LLETZ remained the most cost-effective treatment up to a threshold of £31,500, but laser conisation became the most cost-effective treatment above that threshold., Conclusions: LLETZ is the most cost-effective treatment for both younger and older women. However, for older women, more radical excision with laser conisation could also be considered if the NHS is willing to spend more than £31,500 to avert one CIN2+ recurrence., (© 2024 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
40. Economic Evaluation of anti-epileptic Medicines for Autistic Children with Epilepsy.
- Author
-
Tinelli M M, Roddy A, Knapp M, Arango C, Mendez MA, Cusack J, Murphy D, Canitano R, Oakley B, and Quoidbach V
- Subjects
- Humans, Child, Carbamazepine therapeutic use, Carbamazepine economics, Spain, Ireland, Italy, Gabapentin therapeutic use, Oxcarbazepine therapeutic use, England, Male, gamma-Aminobutyric Acid therapeutic use, gamma-Aminobutyric Acid economics, gamma-Aminobutyric Acid analogs & derivatives, Female, Amines therapeutic use, Amines economics, Anticonvulsants therapeutic use, Anticonvulsants economics, Epilepsy drug therapy, Epilepsy economics, Cost-Benefit Analysis, Autistic Disorder drug therapy, Autistic Disorder economics
- Abstract
We examine the cost-effectiveness of treating epilepsy with anti-epileptic medicines in autistic children, looking at impacts on healthcare providers (in England, Ireland, Italy and Spain) and children's families (in Ireland). We find carbamazepine to be the most cost-effective drug to try first in children with newly diagnosed focal seizures. For England and Spain, oxcarbazepine is the most cost-effective treatment when taken as additional treatment for those children whose response to monotherapy is suboptimal. In Ireland and Italy, gabapentin is the most cost-effective option. Our additional scenario analysis presents the aggregate cost to families with autistic children who are being treated for epilepsy: this cost is considerably higher than healthcare provider expenditure., (© 2023. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
41. Costs and benefits of scaling psychosocial interventions during the perinatal period in England: A simulation modelling study.
- Author
-
Bauer A, Gregoire A, Tinelli M, and Knapp M
- Subjects
- Humans, England, Female, Pregnancy, Psychosocial Intervention methods, Psychosocial Intervention economics, Perinatal Care economics, Cost-Benefit Analysis
- Abstract
Background: Globally, guidance recommends the integration of mental health into maternal and child healthcare to address common maternal mental health problems during the perinatal period. However, implementing this in the real-world requires substantial resource allocations., Objective: The aim of this study was to estimate the likely costs and consequences linked to scaling the delivery of treatment (in the form of psychosocial interventions) during the perinatal period., Design: Simulation modelling., Setting(s): England., Methods: Costs and consequences were modelled for three scenarios of assumed provision of services, whereby one referred to the projected provision under current government plans, with no additional scaling up of treatment. The other two scenarios referred to additional scaling of treatment: in one scenario, this referred to the provision of treatment by midwives and health visitors trained in the routine enquiry about mental health and delivery of psychosocial interventions; in the other scenario this referred to an expanded provision by primary mental health services. For each scenario and in yearly intervals (covering a ten-year period, 2015 to 2024), unit cots and outcomes were assigned to the activities women were assumed to receive (routine enquiry, assessment, treatment, care coordination). All costs were in 2020 pounds sterling. Data sources for the modelling included: published findings from randomised controlled trials; national unit cost source; national statistics; and expert consultation., Results: If the projected treatment gap was to be addressed, an estimated additional 111,154 (50,031) women would be accessing treatment in 2015 (2024). Estimated total costs (including cost offsets) in the scenario of projected provision under current government plans would be £73.5 million in 2015 and £95.2 million in 2024, whilst quality-adjusted life years gained would be 901 and 928 respectively. Addressing the treatment gap through provision by trained midwives and health visitors could mean additional costs of £7.3 million in 2015 but lower costs of £18.4 million in 2024. The additional quality-adjusted life years gained are estimated at 2096 in 2015 and 1418 in 2024. A scenario in which the treatment gap would be met by primary mental health services was likely to be more costly and delivered less health gains., Conclusions: Findings from this modelling study suggest that scaling the integration of mental health care into routinely delivered care for women during the perinatal period might be economically viable., Registration: N/A., Tweetable Abstract: Integrating mental health into maternal and child healthcare might generate economic benefits new study by @a_annettemaria and @knappem @CPEC_LSE finds #increasing access to treatment for women with perinatal mental health problems., Competing Interests: Declaration of Competing Interest Dr Alain Gregoire is founder and honorary president of the Maternal Mental Health Alliance, which funded the research. He was not involved in decisions concerning the funding of the research. The other authors have no conflict of interest to declare., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
42. A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.
- Author
-
Barilà G, Quaglia FM, Furlan A, Pescosta N, Bonalumi A, Marcon C, Pascarella A, Tinelli M, De March E, Lico A, Sartori R, Clissa C, De Sabbata G, Nappi D, Porrazzo M, De Marchi R, Pavan L, Tosetto A, Gherlinzoni F, Krampera M, Bassan R, Patriarca F, Semenzato G, and Zambello R
- Subjects
- Humans, Lenalidomide adverse effects, Bortezomib adverse effects, Dexamethasone adverse effects, Neoplasm Recurrence, Local drug therapy, Antineoplastic Combined Chemotherapy Protocols adverse effects, Multiple Myeloma drug therapy
- Abstract
Treatment of lenalidomide refractory (Len-R) multiple myeloma (MM) patients still represents an unmet clinical need. In the last years, daratumumab-bortezomib-dexamethasone (D-VD) combination was extensively used in this setting, even though only a small fraction of Len-R patients was included in the pivotal trial. This real-life study aimed to evaluate the efficacy and safety of the D-VD regimen in a cohort that exclusively enrolled Len exposed or refractory MM patients. The study cohort included 57 patients affected by relapsed/refractory MM. All patients were previously exposed to Len, with 77.2% being refractory. The overall response rate (ORR) was 79.6% with 43% of cases obtaining at least a very good partial response (VGPR). The D-VD regimen showed a favorable safety profile, with low frequency of grade 3-4 adverse events, except for thrombocytopenia observed in 21.4% of patients. With a median follow-up of 13 months, median progression-free survival (PFS) was 17 months. No significant PFS differences were observed according to age, ISS, LDH levels, type of relapse, and high-risk FISH. Len exposed patients displayed a PFS advantage as compared to Len refractory patients (29 vs 16 months, p = 0.2876). Similarly, patients treated after Len maintenance showed a better outcome as compared to patients who had received a full-dose Len treatment (23 vs 13 months, p = 0.1728). In conclusion, our real-world data on D-VD combination showed remarkable efficacy in Len-R patients, placing this regimen as one of the standards of care to be properly taken into account in this MM setting., (© 2023. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
43. Economic analysis of early intervention for autistic children: findings from four case studies in England, Ireland, Italy, and Spain.
- Author
-
Tinelli M, Roddy A, Knapp M, Arango C, Mendez MA, Cusack J, Murphy D, Canitano R, Oakley B, and Quoidbach V
- Subjects
- Child, Preschool, Child, Humans, Ireland, Spain, England, Communication, Cost-Benefit Analysis, Autistic Disorder therapy
- Abstract
Background: Many autistic children experience difficulties in their communication and language skills development, with consequences for social development into adulthood, often resulting in challenges over the life-course and high economic impacts for individuals, families, and society. The Preschool Autism Communication Trial (PACT) intervention is effective in terms of improved social communication and some secondary outcomes. A previously published within-trial economic analysis found that results at 13 months did not support its cost-effectiveness. We modeled cost-effectiveness over 6 years and across four European countries., Methods: Using simulation modeling, we built on economic analyses in the original trial, exploring longer-term cost-effectiveness at 6 years (in England). We adapted our model to undertake an economic analysis of PACT in Ireland, Italy, and Spain. Data on resource use were taken from the original trial and a more recent Irish observational study., Results: PACT is cost-saving over time from a societal perspective, even though we confirmed that, at 13 months post-delivery, PACT is more expensive than usual treatment (across all countries) when given to preschool autistic children. After 6 years, we found that PACT has lower costs than usual treatment in terms of unpaid care provided by parents (in all countries). Also, if we consider only out-of-pocket expenses from an Irish study, PACT costs less than usual treatment., Discussion: PACT may be recommended as a cost-saving early intervention for families with an autistic child.
- Published
- 2023
- Full Text
- View/download PDF
44. Autism care pathway in Europe.
- Author
-
Mendez MA, Oakley B, Canitano R, San José-Cáceres A, Tinelli M, Knapp M, Cusack J, Parellada M, Violland P, Derk Plas JR, Canal-Bedia R, Bejarano-Martin A, Murphy DGM, Quoidbach V, and Arango C
- Subjects
- Child, Adolescent, Humans, Infant, Newborn, Infant, Child, Preschool, Quality of Life, Critical Pathways, Europe, Caregivers, Autistic Disorder diagnosis, Autistic Disorder therapy
- Abstract
Background: Autism is a lifelong complex neurodevelopmental condition that affects brain development and behaviour with significant consequences for everyday life. Despite its personal, familial, and societal impact, Europe-wide harmonised guidelines are still lacking for early detection, diagnosis, and intervention, leading to an overall unsatisfactory autistic person and carer journey., Methods: The care pathway for autistic children and adolescents was analysed in Italy, Spain and the UK from the perspective of carers (using a survey aimed at caregivers of autistic children 0-18 years old), the autistic community, and professionals in order to identify major barriers (treatment gaps) preventing carers from receiving information, support, and timely screening/diagnosis and intervention., Results: Across all three countries, analysis of the current care pathway showed: long waits from the time carers raised their first concerns about a child's development and/or behaviour until screening and confirmed diagnosis; delayed or no access to intervention once a diagnosis was confirmed; limited information about autism and how to access early detection services; and deficient support for families throughout the journey., Conclusions: These findings call for policy harmonisation in Europe to shorten long wait times for diagnosis and intervention and therefore, improve autistic people and their families' journey experience and quality of life.
- Published
- 2023
- Full Text
- View/download PDF
45. Whole-Genome Sequencing and Molecular Analysis of Ceftazidime-Avibactam-Resistant KPC-Producing Klebsiella pneumoniae from Intestinal Colonization in Elderly Patients.
- Author
-
Errico G, Del Grosso M, Pagnotta M, Marra M, Carollo M, Cerquetti M, Fogato E, Cesana E, Gentiloni Silverj F, Zabzuni D, Rossini A, Pantosti A, Tinelli M, Monaco M, and Giufrè M
- Abstract
Ceftazidime-avibactam (CAZ-AVI) is an active antibiotic combination of a β-lactam-β-lactamase inhibitor against carbapenemase-producing Enterobacterales. Reports of resistance to CAZ-AVI other than metallo-β-lactamases have increased in recent years. The aim of this study was to analyze KPC- Klebsiella pneumoniae (KP) isolates resistant to CAZ-AVI from the intestinal carriage of hospitalized elderly patients in Italy, in February 2018-January 2020. Characterization of CAZ-AVI-resistant KP isolates, including MLST, resistome, virulome and plasmid content, was performed by WGS analysis. Out of six CAZ-AVI-resistant KP isolates, three belonged to ST101 and three to ST512; two isolates produced KPC-3 (both ST512), four had mutated KPC-3 (KPC-31, in ST101 and ST512, and KPC-46, both ST101). All CAZ-AVI-resistant KP isolates were multidrug-resistant and carried several resistance genes. The yersiniabactin ybt 9 gene cluster was present in all ST101 isolates, while, in ST512 isolates, no virulence genes were detected. Several plasmids were detected: IncF was present in all isolates, as well as IncR and Col440 in ST101 and IncX3 in ST512 isolates. In conclusion, it is important to monitor the circulation of K. pneumoniae resistant to CAZ-AVI to prevent the spread of clones causing difficult-to-treat infections. The presence of mutated KPC-3 in high-risk K. pneumoniae clones resistant to CAZ-AVI in hospitalized patients deserves attention.
- Published
- 2023
- Full Text
- View/download PDF
46. Autism with co-occurring epilepsy care pathway in Europe.
- Author
-
Mendez MA, Canitano R, Oakley B, San José-Cáceres A, Tinelli M, Knapp M, Cusack J, Parellada M, Violland P, Derk Plas JR, Murphy DGM, Quoidbach V, and Arango C
- Subjects
- Quality of Life, Italy, Spain, United Kingdom, Caregivers, Anticonvulsants therapeutic use, Evidence-Based Medicine, Humans, Infant, Newborn, Infant, Child, Preschool, Child, Adolescent, Electroencephalography, Intellectual Disability complications, Male, Female, Autistic Disorder complications, Autistic Disorder diagnosis, Epilepsy complications, Epilepsy diagnosis, Epilepsy therapy, Critical Pathways
- Abstract
Background: Autism and epilepsy often occur together. Epilepsy and other associated conditions have a substantial impact on the well-being of autistic people and their families, reduce quality of life, and increase premature mortality. Despite this, there is a lack of studies investigating the care pathway of autistic children with co-occurring epilepsy in Europe., Methods: We analyzed the care pathway for autistic children with associated epilepsy in Italy, Spain, and the United Kingdom from the perspective of caregivers (using a survey aimed at caregivers of autistic children 0-18 years old), the autistic community, and professionals, in order to identify major barriers preventing caregivers and autistic children from receiving timely screening and treatment of possible co-occurring epilepsy., Results: Across all three countries, an analysis of the current care pathway showed a lack of systematic screening of epilepsy in all autistic children, lack of treatment of co-occurring epilepsy, and inappropriate use of antiepileptic drugs. A major challenge is the lack of evidence-based harmonized guidelines for autism with co-occurring epilepsy in these countries., Conclusions: Our findings show both heterogeneity and major gaps in the care pathway for autism with associated epilepsy and the great efforts that caregivers must make for timely screening, diagnosis, and adequate management of epilepsy in autistic children. We call for policy harmonization in Europe in order to improve the experiences and quality of life of autistic people and their families.
- Published
- 2023
- Full Text
- View/download PDF
47. Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study.
- Author
-
Margalit I, Tiseo G, Ripa M, Borghi V, Green H, Prendki V, Riccardi N, Perego GB, Grembiale A, Galli L, Tinelli M, Castagna A, Mussini C, Falcone M, and Yahav D
- Subjects
- Aged, Humans, Female, Male, COVID-19 Drug Treatment, Retrospective Studies, Hospital Mortality, Antiviral Agents therapeutic use, Alanine therapeutic use, COVID-19
- Abstract
Introduction: The effect of remdesivir on COVID-19 mortality remains conflicting. Elderly individuals are at risk for poor COVID-19 outcomes. We aimed to assess the effect of remdesivir on COVID-19 mortality among elderly individuals, using real-world data., Methods: Retrospective multinational cohort of individuals aged ≥65 years, hospitalized with COVID-19 in six medical centres between January 2020 and May 2021. Associations with in-hospital mortality were evaluated using a multivariable logistic regression model with propensity score adjustment for remdesivir therapy and while implementing generalized estimating equations to control for centre effect. Sensitivity analysis was performed by stratification according to the degree of respiratory support., Results: Of 3010 individuals included, 2788 individuals required either oxygen supplementation or non-invasive/invasive mechanical ventilation, 489 (16%) were treated with remdesivir, and 836 (28%) died. Median age was 77 (IQR 70-84) years and 42% were women. Remdesivir was the only therapeutic intervention associated with decreased mortality [adjusted OR (aOR) 0.49, 95% CI 0.37-0.66, P < 0.001]. This protective effect was shown for individuals requiring oxygen support and non-invasive mechanical ventilation, while no association was found among individuals necessitating invasive mechanical ventilation.Risk factors for mortality included invasive ventilation (aOR 5.18, 95% CI 2.46-10.91, P < 0.001), higher serum creatinine (aOR 1.25, 95% CI 1.09-1.43, P = 0.001) and dyspnoea (aOR 1.40, 95% CI 1.07-1.84, P = 0.015) on presentation, and other non-modifiable factors, such as comorbidities., Conclusions: Among elderly individuals hospitalized with COVID-19, remdesivir carries survival benefit for those with moderate to severe disease. Its role among individuals with critical illness should be further assessed., (© The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
48. Exclusion of older adults and immunocompromised individuals in influenza, pneumococcal and COVID-19 vaccine trials before and after the COVID-19 pandemic.
- Author
-
Bukan K, Pearce-Slade T, Eiberg M, Tinelli M, Yahav D, Tuells J, Epaulard O, Holler JG, Roed C, Søborg C, Jensen JS, and Harboe ZB
- Subjects
- Humans, Aged, COVID-19 Vaccines therapeutic use, Pandemics prevention & control, Pneumococcal Vaccines therapeutic use, Influenza, Human epidemiology, Influenza, Human prevention & control, Influenza Vaccines therapeutic use, COVID-19 epidemiology, COVID-19 prevention & control
- Abstract
Background: Older adults and immunocompromised individulas are often excluded from vaccine trials., Aim: We hypothesised that during the coronavirus disease 2019 (COVID-19) pandemic, the proportion of trials excluding these patients decreased., Methods: Using the US Food and Drug Administration and and European Medicines Agency search engines, we identified all vaccines approved against pneumococcal disease, influenza (quadrivalent vaccines), and COVID-19 from 2011 to 2021. Study protocols were screened for direct and indirect age exclusion criteria and exclusion of immunocompromised individuals. In addition, we reviewed the studies with no explicit exclusion criteria and investigated the actual inclusion of those individuals., Results: We identified 2024 trial records; 1702 were excluded (e.g., use of other vaccine or risk group); and 322 studies were eligible for our review. Among the pneumococcal and influenza vaccine trials (n = 193), 81 (42%) had an explicit direct age exclusion, and 150 (78%) had an indirect age-related exclusion. In total, 163 trials (84%) trials were likely to exclude older adults. Among the COVID-19 vaccine trials (n = 129), 33 (26%) had direct age exclusion and 82 (64%) had indirect age exclusion; in total, 85 (66%) trials were likely to exclude older adults. Therefore was a 18% decrease in the proportion of trials with age-related exclusion between 2011 and 2021 (only influenza and pneumococcal vaccine trials) and 2020-2021 (only COVID-19 vaccine trials) (p = 0.014). In a sub-analysis assessing observational and randomised trials, the decrease was 25% and 9%, respectively. Immunocompromised individuals were included in 87 (45%) of the pneumococcal and influenza vaccine trials compared with 54 (42%) of the COVID-19 vaccine trials (p = 0.058)., Conclusions: During the COVID-19 pandemic, we found a decrease in the exclusion of older adults from vaccine trials but no significant change in the inclusion of immunocompromised individulas., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
49. Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score.
- Author
-
Tiseo G, Margalit I, Ripa M, Borghi V, Green H, Prendki V, Riccardi N, Dishon Y, Perego GB, Grembiale A, Galli L, Tinelli M, Castagna A, Mussini C, Yahav D, Paul M, and Falcone M
- Subjects
- Aged, Humans, Retrospective Studies, Risk Assessment, Risk Factors, Hospitals, COVID-19
- Abstract
Objective: To identify predictors of 30-day survival in elderly patients with coronavirus disease 2019 (COVID-19)., Methods: Retrospective cohort study including patients with COVID-19 aged ≥65 years hospitalized in six European sites (January 2020 to May 2021). Data on demographics, comorbidities, clinical characteristics, and outcomes were collected. A predictive score (FLAMINCOV) was developed using logistic regression. Regression coefficients were used to calculate the score. External validation was performed in a cohort including elderly patients from a major COVID-19 centre in Israel. Discrimination was evaluated using the area under the receiver operating characteristic curve (AUC) in the derivation and validation cohorts. Survival risk groups based on the score were derived and applied to the validation cohort., Results: Among 3010 patients included in the derivation cohort, 30-day survival was 74.5% (2242/3010). The intensive care unit admission rate was 7.6% (228/3010). The model predicting survival included independent functional status (OR, 4.87; 95% CI, 3.93-6.03), a oxygen saturation to fraction of inspired oxygen (SpO
2 /FiO2 ) ratio of >235 (OR, 3.75; 95% CI, 3.04-4.63), a C-reactive protein level of <14 mg/dL (OR, 2.41; 95% CI, 1.91-3.04), a creatinine level of <1.3 (OR, 2.02; 95% CI, 1.62-2.52) mg/dL, and absence of fever (OR, 1.34; 95% CI, 1.09-1.66). The score was validated in 1174 patients. The FLAMINCOV score ranges from 0 to 15 and showed good discrimination in the derivation (AUC, 0.79; 95% CI, 0.77-0.81; p < 0.001) and validation cohorts (AUC, 0.79; 95% CI, 0.76-0.81; p < 0.001). Thirty-day survival ranged from 39.4% (203/515) to 95.3% (634/665) across four risk groups according to score quartiles in the derivation cohort. Similar proportions were observed in the validation set., Discussion: The FLAMINCOV score identifying elderly with higher or lower chances of survival may allow better triage and management, including intensive care unit admission/exclusion., (Copyright © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
50. Study protocol: hypnosis versus standard care for shoulder dislocation reduction in the emergency department - a multicentre, randomised, controlled study protocol.
- Author
-
Tinelli M, Guler N, Goetz C, Aim P, Marchionni S, Ouamara N, Cipolat L, Demarquet M, Seris E, Moreau A, Durand G, Douplat M, Lavignon JP, Hingray C, and Abensur Vuillaume L
- Subjects
- Humans, Research Design, Emergency Service, Hospital, Randomized Controlled Trials as Topic, Multicenter Studies as Topic, Shoulder Dislocation therapy, Hypnosis
- Abstract
Introduction: Anterior shoulder dislocation is a common reason for consultation at the emergency department (ED). Hypnosis could be a safe and effective alternative therapy for pain relief during shoulder dislocation reduction but nowadays, evidence is not sufficient. The main objective of this study is to show that reduction under hypnosis is associated with a decrease in the use of analgesic compared with usual care., Methods and Analysis: We will conduct an interventional, controlled, multicentre, randomised study. A total of 44 patients with shoulder dislocation will be randomised in two groups: the hypnosis group (N=22) and the usual care group (N=22). The primary endpoint will be the comparison of morphine equivalent analgesic consumption during a shoulder dislocation reduction manoeuvre. Secondary endpoints will include haemodynamic parameters monitoring, patient and practitioner satisfaction using a Likert scale, use of coanalgesic or sedative drugs, number of reduction attempts and time spent at ED. Adverse events will be recorded. Statistical analysis will include parametric tests, multivariate linear regression and descriptive statistics., Ethics and Dissemination: This study has received ethics approval from the Comité de Protection des Personnes of Sud-Est IV on 03/11/2021 (ANSM informed on 19 November 2021). The results will be published in scientific articles and communicated in national and international conferences., Trial Registration Number: ClinicalTrial.gov: NCT04992598; National Clinical trial no ID RCB : 2021-A01382-39., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.